Publication
Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply.
Journal Paper/Review - Feb 8, 2024
Huober Jens, Thürlimann Beat, Dietrich Daniel
Units
PubMed
Doi
Contact
Citation
Huober J, Thürlimann B, Dietrich D. Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply. JAMA Oncol 2024
Type
Journal Paper/Review (English)
Journal
JAMA Oncol 2024
Publication Date
Feb 8, 2024
Issn Electronic
2374-2445